| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5588344 | Metabolism | 2017 | 30 Pages |
Abstract
These findings demonstrate that podocyte PTP1B deficiency attenuates hyperglycemia-induced renal damage and suggest that PTP1B may present a therapeutic target in renal injury.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Yoshihiro Ito, Ming-Fo Hsu, Ahmed Bettaieb, Shinichiro Koike, Aline Mello, Miguel Calvo-Rubio, Jose M. Villalba, Fawaz G. Haj,